InvestorsHub Logo
Followers 42
Posts 1152
Boards Moderated 0
Alias Born 03/24/2021

Re: pumper_stumper post# 145508

Friday, 03/25/2022 9:46:23 AM

Friday, March 25, 2022 9:46:23 AM

Post# of 198826
I usually agree with your points, but the idea here is that ENZC used machine learning on virus data to quickly and thoroughly find immutable virus sites. This isn't too far fetched; early adopters of machine learning are disrupting in other industries as well for the same reasons. Properly written AI is fast at uncovering obscure relationships in big data. Don't forget they had help from Intel (and probably had access to a supercomputer)

https://www.intel.com/content/www/us/en/healthcare-it/resources/enzolytics-whitepaper.html




With regards to Big Pharma and today's PR, here's how ENZC framed its patent applications a year ago:

CEO Charles Cotropia stated: "While we recognize that the production of the therapeutics, we are creating takes time, we have immediately taken the necessary steps to protect our discoveries using U.S. and foreign patents. As a small biotech, this puts us on the same stage as big pharma.
https://www.otcmarkets.com/stock/enzc/news/Enzolytics-Announces-the-Discovery-and-Patenting-of-8-Newly-Identified-Conserved-Target-Sites-on-the-HIV-1-Virus?id=292798


I edit too much! Refresh any of my posts within the first few minutes to get silly little updates and clarifications. :)